S

Seres Therapeutics

470 employees

Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Microbiome
Biopharma
Health Care

Date founded

2010

Funding rounds raised

Total raised

$110M

from 8 investors over 8 rounds

S

Seres Therapeutics raised $110M on April 27, 2023

Investors: Oaktree Capital Management, L.P.

S

Seres Therapeutics raised undisclosed on November 16, 2020

Investors: RA Capital Management, L.P.

S

Seres Therapeutics raised $5.6M on October 1, 2017

Investors: CARB-X

S

Seres Therapeutics raised $48M on December 2, 2014

Investors: Flagship Ventures

S

Seres Therapeutics raised $10M on May 23, 2014

Investors: Flagship Ventures and Mayo Clinic, Center for Innovation

S

Seres Therapeutics raised $11M on November 21, 2013

Investors: Flagship Ventures

S

Seres Therapeutics raised undisclosed on January 1, 2004

Investors: Sofinnova Ventures, Russia technology fund

FAQ